Rachel Winter discusses the intervention to support the Japanese yen, AstraZeneca’s talks about a possible merger, and the first set of results from SpaceX.
Sign up to receive the latest news from Killik & Co, including our Market Update and Killik Explains educational videos, and be one of the first to hear about upcoming events and webinars. You can unsubscribe at any time and learn how we use your data in our Privacy Policy.